About Fujifilm Diosynth Biotechnology
Fujifilm Diosynth Biotechnology is a Healthcare company based in Stockton On Tees (United Kingdom) founded in 2011. Biologics and vaccines contract development and manufacturing are provided. Its chief executive, as recorded, is Lars Petersen. Fujifilm Diosynth Biotechnology offers products and services including Biologics Manufacturing, Gene Therapy Services, and Cell Therapy Services. Its focus areas include Biopharma Outsourcing, CDMO and Biologics. Its legal entity is FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED.
Company details
Fujifilm Diosynth Biotechnologies was founded in 2011 as a contract development and manufacturing organization in the biotechnology sector. Biopharmaceutical services focused on biologics and vaccines are delivered, including process development, clinical and commercial manufacturing, and quality assurance. Operations support clients worldwide in advancing therapeutic pipelines. Leadership is held by CEO Lars Petersen and Chairman Toshihisa Lida, with expertise centered on microbial and mammalian cell technologies.
- Headquarters Stockton On Tees, United Kingdom
- SectorsHealthcare
- Website fujifilmdiosynth.com
- Social LinkedIn X Facebook
- Legal Name Fujifilm Diosynth Biotechnologies Uk Limited
- Annual Revenue$177.37 M (USD)1as on Mar 31, 2023
- Net Profit$1.09 M (USD)-95as on Mar 31, 2023
- EBITDA$120.58 K (USD)-100as on Mar 31, 2023
- Latest Funding Round$659.49K (USD), Grant
Oct 2016
- Investors
Products & Services of Fujifilm Diosynth Biotechnology
Fujifilm Diosynth Biotechnology offers a comprehensive portfolio of products and services, including Biologics Manufacturing, Gene Therapy Services, and Cell Therapy Services.
Contract production of biologics using cGMP standards
Development and manufacturing for viral gene therapies
Process and analytical development for stem cell therapies
Funding Insights of Fujifilm Diosynth Biotechnology
- Total Rounds 2
- Last Round Grant — $659,488
- First Round $425,777
(Jan 2015)
- Investors Count 1
All 2 funding rounds of Fujifilm Diosynth Biotechnology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2016 | $659,488 | Grant | – | – | |
| Jan 2015 | $425,777 | Grant | – | – | – |
1 investors in total: 1 institutional.
Investors in Fujifilm Diosynth Biotechnology
Fujifilm Diosynth Biotechnology has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Fujifilm Diosynth Biotechnology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Fujifilm Diosynth Biotechnology
633 people are tracked at Fujifilm Diosynth Biotechnology (178 in leadership, 455 in team).
| Name | Role | Group |
|---|---|---|
Lars Petersen | CEO & President | Leadership |
Toshihisa Lida | Chairman | Leadership |
Isaac Davis | Director, Commercial Development, Advanced Therapies | Leadership |
Cesar Augusto Rodriguez | Director, Pharmaceutical Quality Systems | Leadership |
Joe Rettinger | Head Of Program Operations | Leadership |
Ezekiel Sauceda | Associate Director Program Management | Leadership |
Matt Laseur | Director, QA Operations At Fujifilm Biotechnologies | Leadership |
Dinah Adeltoft | Director QC Testing Teams | Leadership |
Mena Chapman | Director QA Operations | Leadership |
Matt Dixon | Senior Director, Quality Assurance Operations | Leadership |
Rich Anderson | Associate Director, Quality Control | Leadership |
Kosmas Balourdos | Director-global Alliance Management | Leadership |
Benjamin Piot | Global Key Account Director | Leadership |
Chad Cecil | Associate Director QC - Head Of Microbiology | Leadership |
Johan Åhman | Associate Director QC Chemistry | Leadership |
Nadjah Lara | Senior Director Quality Control | Leadership |
Henrik Ernlund Pedersen | Senior Vice President, Commercial | Leadership |
Klavs Bay Rasmussen | Head Of Indirect Procurement | Leadership |
Frederik Willmes | Interim Head Of Global Sourcing & Procurement | Leadership |
Damaris Moturi | Associate Director QC | Leadership |
613 more people are available in the full profile.
Complete people profiles for Fujifilm Diosynth Biotechnology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Fujifilm Diosynth Biotechnology
3 dated milestones of Fujifilm Diosynth Biotechnology across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Fujifilm Diosynth Biotechnology is founded.
- Funding First funding round of $426K.
- Funding Latest funding round, Grant, of $659K.
Web traffic of Fujifilm Diosynth Biotechnology
Websites that share an audience with Fujifilm Diosynth Biotechnology (fujifilmdiosynth.com).
Websites whose visitors overlap most with Fujifilm Diosynth Biotechnology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pharmaceutical-tech.com | 100% | #1,417,513 | View details | ||
| syncobiopartners.com | 98% | View details | |||
| vgxii.com | 97% | 2.9K | #6,447,856 | View details | |
| endpts.com | 93% | 8.4K | #3,077,209 | View details | |
| radicoremedies.com | 61% | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fujifilm Diosynth Biotechnology
Complete news archive for Fujifilm Diosynth Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fujifilm Diosynth Biotechnology
Fujifilm Diosynth Biotechnology was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Fujifilm Diosynth Biotechnology is headquartered in Stockton On Tees, United Kingdom.
Lars Petersen is the CEO of Fujifilm Diosynth Biotechnology, as recorded in our data.
Annual revenue of Fujifilm Diosynth Biotechnology is $177.37M as on Mar 31, 2023.
Fujifilm Diosynth Biotechnologies was founded in 2011 as a contract development and manufacturing organization in the biotechnology sector. Biopharmaceutical services focused on biologics and vaccines are delivered, including process development, clinical and commercial manufacturing, and quality assurance. Operations support clients worldwide in advancing therapeutic pipelines. Leadership is held by CEO Lars Petersen and Chairman Toshihisa Lida, with expertise centered on microbial and mammalian cell technologies.
Fujifilm Diosynth Biotechnology offers Biologics Manufacturing, Gene Therapy Services, and Cell Therapy Services.
Fujifilm Diosynth Biotechnology has 1 investor. Key investors include European Union.
Fujifilm Diosynth Biotechnology operates through Fujifilm Diosynth Biotechnologies Uk Limited.